SAGE THERAPEUTICS INC

CUSIP: 78667J108 Class: Common Stock

Trexquant Investment LP's Holding History (CIK: 0001633445)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 223,121 Value ($000) $2,035 Avg Close Range
Q1 2025
Shares 633,625 Value ($000) $5,037 Avg Close Range
Q4 2024
Shares 144,662 Value ($000) $786 Avg Close Range
Q3 2024
Shares 175,661 Value ($000) $1,268 Avg Close Range
Q2 2024
Shares 315,243 Value ($000) $3,424 Avg Close Range
Q1 2024
Shares 27,858 Value ($000) $522 Avg Close Range
Q4 2023
Shares 103,097 Value ($000) $2,234 Avg Close Range
Q4 2022
Shares 20,249 Value ($000) $772 Avg Close Range
Q3 2022
Shares 21,594 Value ($000) $846 Avg Close Range
Q4 2021
Shares 6,599 Value ($000) $281 Avg Close Range
Q1 2020
Shares 24,897 Value ($000) $715 Avg Close Range
Q4 2018
Shares 2,164 Value ($000) $207 Avg Close Range
Q3 2018
Shares 3,523 Value ($000) $498 Avg Close Range
Q2 2018
Shares 20,205 Value ($000) $3,163 Avg Close Range
Q1 2017
Shares 6,108 Value ($000) $434 Avg Close Range
Q4 2016
Shares 9,900 Value ($000) $505 Avg Close Range
Q3 2016
Shares 17,800 Value ($000) $820 Avg Close Range
Q1 2015
Shares 25,815 Value ($000) $1,296 Avg Close Range